Enhancing Renal Graft Function During Donor Anesthesia
Recruiting
N/A
Interventional Study
Renal Failure Chronic
Transplant;Failure,Kidney
Anesthesia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 60 (estimated)
- Sponsor
- Nazmy Edward Seif · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplanted kidney. The aim of this study is to assess \& compare the effectiveness of 3 different modalities in this respect: Mannitol, Dopamine and adequate hydration.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* end-stage renal disease, for living-donor kidney transplantation
Exclusion Criteria:
* severe cardiac or hepatic dysfunction
* coagulopathy
Contacts